AU2002230911A1 - Signal-1/signal-2 bifunctional peptide inhibitors - Google Patents

Signal-1/signal-2 bifunctional peptide inhibitors

Info

Publication number
AU2002230911A1
AU2002230911A1 AU2002230911A AU3091102A AU2002230911A1 AU 2002230911 A1 AU2002230911 A1 AU 2002230911A1 AU 2002230911 A AU2002230911 A AU 2002230911A AU 3091102 A AU3091102 A AU 3091102A AU 2002230911 A1 AU2002230911 A1 AU 2002230911A1
Authority
AU
Australia
Prior art keywords
chain
signal
moiety
immune response
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002230911A
Other languages
English (en)
Inventor
Yongbo Hu
Joseph S. Murray
Teruna J Siahaan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Kansas
Original Assignee
University of Kansas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Kansas filed Critical University of Kansas
Publication of AU2002230911A1 publication Critical patent/AU2002230911A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002230911A 2000-12-18 2001-12-17 Signal-1/signal-2 bifunctional peptide inhibitors Abandoned AU2002230911A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/739,466 2000-12-18
US09/739,466 US7786257B2 (en) 2000-12-18 2000-12-18 Signal-1/signal-2 bifunctional peptide inhibitors
PCT/US2001/048632 WO2002050250A2 (en) 2000-12-18 2001-12-17 Signal-1/signal-2 bifunctional peptide inhibitors

Publications (1)

Publication Number Publication Date
AU2002230911A1 true AU2002230911A1 (en) 2002-07-01

Family

ID=24972431

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002230911A Abandoned AU2002230911A1 (en) 2000-12-18 2001-12-17 Signal-1/signal-2 bifunctional peptide inhibitors

Country Status (8)

Country Link
US (1) US7786257B2 (enExample)
EP (2) EP1932539A3 (enExample)
JP (1) JP2004536783A (enExample)
AT (1) ATE400293T1 (enExample)
AU (1) AU2002230911A1 (enExample)
CA (1) CA2432767A1 (enExample)
DE (1) DE60134791D1 (enExample)
WO (1) WO2002050250A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8188218B2 (en) 2006-10-27 2012-05-29 University Of Kansas Bi-functional peptides for multiple sclerosis treatment and diagnosis
US8735154B2 (en) 2006-10-30 2014-05-27 The University Of Kansas Templated islet cells and small islet cell clusters for diabetes treatment
US8016856B2 (en) * 2006-11-30 2011-09-13 Cook Medical Technologies Llc Removable handle for medical device
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
EA023303B1 (ru) 2007-08-15 2016-05-31 Сиркейшиа Лимитед Пептидная композиция для формирования толерантности к клещам домашней пыли и ее применение
WO2009055054A2 (en) * 2007-10-25 2009-04-30 Janda Kim D Antibody-mediated disruption of quorum sensing in bacteria
DE102009040716B4 (de) * 2009-09-10 2011-07-14 Miltenyi Biotec GmbH, 51429 Verwendung von CD154 zur Identifizierung und Abtrennung von nicht-regulatorischen T-Zellen aus einem Gemisch mit regulatorischen T-Zellen
WO2011163568A1 (en) 2010-06-24 2011-12-29 University Of Kansas Conjugates comprising an n-oxime bond and associated methods
EP3498300A1 (en) 2011-07-27 2019-06-19 University of Kansas Templated islet cells and small islet cell clusters for diabetes treatment
CN105708834A (zh) * 2011-10-18 2016-06-29 株式会社爱茉莉太平洋 包含丁香脂素的sirt1活化剂
US11919939B2 (en) * 2017-05-23 2024-03-05 Université De Genève Beta-2-glycoprotein 1 derived peptide and use thereof for treating antiphospholipid syndrome

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5844095A (en) * 1991-06-27 1998-12-01 Bristol-Myers Squibb Company CTLA4 Ig fusion proteins
DE59310308D1 (de) * 1992-06-11 2002-11-21 Merck Patent Gmbh Verfahren und Mittel zum Nachweis von Listerien
US5540926A (en) 1992-09-04 1996-07-30 Bristol-Myers Squibb Company Soluble and its use in B cell stimulation
DE69840326D1 (de) 1997-03-27 2009-01-22 Csl Ltd Steigerung der immunantwort unter verwendung von zielgerichteten molekülen
EP1246643A4 (en) * 1999-10-14 2005-05-11 Jeffery A Ledbetter DNA VACCINES ENCODING ANTIGEN ASSOCIATED WITH CD40-BINDING DOMAIN

Also Published As

Publication number Publication date
EP1932539A2 (en) 2008-06-18
JP2004536783A (ja) 2004-12-09
ATE400293T1 (de) 2008-07-15
US7786257B2 (en) 2010-08-31
US20050107585A1 (en) 2005-05-19
EP1404362A4 (en) 2005-06-01
EP1404362A2 (en) 2004-04-07
CA2432767A1 (en) 2002-06-27
WO2002050250A2 (en) 2002-06-27
EP1404362B1 (en) 2008-07-09
WO2002050250A3 (en) 2004-01-08
DE60134791D1 (de) 2008-08-21
EP1932539A3 (en) 2008-10-29

Similar Documents

Publication Publication Date Title
EP1404362A4 (en) SIGNAL-1 / SIGNAL-2-BIFUNCTIONAL PEPTIDE INHIBITORS
WO2004083251A3 (en) Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
SE8703012L (sv) Skyddshandske
DE69005786D1 (de) Mit Verbrennungsgas betriebenes Eintreibwerkzeug für Befestigungsmittel.
PT891428E (pt) Sub-unidade catalitica fosfatidilinositol 3-cinase p110 delta
ZA907079B (en) Novel peptidase and isomerase inhibitors
BG101077A (bg) Пептиди
ATE260389T1 (de) Bausatz mit platten- oder leistenförmigen bauteilen und klammer hierfür
NO974342D0 (no) Trombininhibitorer basert på aminosyresekvensen til hirudin
NZ616594A (en) Antibodies to opgl
EP0672863A3 (en) Coal dust burner.
DK0387231T3 (da) Hidtil ukendte inhibitorer for retroviral protease
NO994848L (no) Friksjonsreduserende additiver for brennstoffer og smöremidler
DK1908772T3 (da) Polypeptider og polynucleinsyrer af phorphorymonas gingivalis
DK0498784T3 (da) Hæmmere af retroviral protease
DK524388D0 (da) Forbraending af kul med et fluidiseret forbraendingsleje
DE68927630D1 (de) Analoge von Peptrolsubstraten
IL90220A0 (en) Anticoagulant peptide alcohols
TR199700699T1 (en) Bas�n� g�stergesi.
EP1293567A4 (en) GPR8 LIGAND AND DAFUER ENCODING DNA (02.01.02)
DK431189D0 (da) Peptidaseinhibitorer
BR0110969A (pt) Inibição de pepsina por alginatos
AU2002346871A1 (en) Compounds for determining the activity of phospholipase a?2?
BRPI0416201A (pt) métodos para purificação de toxina coqueluche e peptìdios neles utilizáveis
DE69233666D1 (de) Verzweigte Peptide zum Nachweis von Antikörpern